| | |
| Clinical data | |
|---|---|
| Routes of administration | By mouth |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C24H34O3S |
| Molar mass | 402.59 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Spiroxasone (INN , USAN ) is a synthetic, steroidal antimineralocorticoid of the spirolactone group which was developed as a diuretic and antihypertensive agent but was never marketed. [1] [2] It was synthesized and assayed in 1963. [1] The drug is 7α-acetylthiospirolactone with the ketone group removed from the C17α spirolactone ring. [1] Similarly to other spirolactones like spironolactone, spiroxasone also possesses antiandrogen activity. [3] [4]
Spiroxasone [...] is also an anti-androgen [379].